EMGRAF
Main information
- Trade name:
- EMGRAF 10 CAP
- Active ingredient:
- TACROLIMUS
- Available from:
- Emcure
- Dosage:
- 2MG
- Pharmaceutical form:
- CAP
- Composition:
- 10
- Medicine domain:
- Humans
- Medicine type:
- Allopathic drug
Documents
- for the general public:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- for healthcare professionals:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for healthcare professionals.
Localization
- Available in:
-
India
- Language:
- English
Other information
Status
- Source:
- Central Drugs Standard Control Organization
- Last update:
- 09-08-2016
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- Access to this document is only available to registered users.
Register now for full access
19-7-2018
Human medicines European public assessment report (EPAR): Modigraf, tacrolimus, Revision: 11, Authorised
Europe - EMA - European Medicines Agency
19-7-2018
Human medicines European public assessment report (EPAR): Advagraf, tacrolimus, Revision: 17, Authorised
Europe - EMA - European Medicines Agency
26-1-2018
Human medicines European public assessment report (EPAR): Tacforius, tacrolimus, Revision: 0, Authorised
Europe - EMA - European Medicines Agency